We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Report on Public Health England's recommended consequence assessment methodology, to meet the REPPIR 2019 requirements.
Product Safety Report for Fabrique Par Rodis White Secret Unifying Complexion Serum presenting a serious chemical risk.
The FleX competition supported the development and demonstration of innovative energy flexibility exchange solutions.
This report presents the systems architecture that includes the indicators for assessing the benefits of research investments
Reports of pigment changes in ocular tissue, skin, lips or nails.
Case study from Plextek who pitched their ideas to industry and investors at the CDE Marketplace on 27 April 2016.
Severe infusion-related hypersensitivity reactions have occurred in patients receiving temsirolimus.
Cases of pigmentary maculopathy leading to visual impairment have been reported with pentosan polysulfate, particularly after long-term use at high doses. Ensure patients taking pentosan polysulfate have regular ophthalmic examinations and ask them to promptly seek medical advice in case...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).